| Filed On | Filing |
|---|---|
| 16 Nov 2026 |
Form 4: Deppe Michael J, SVP, Corp. Controller & CAO
Received 11,776 shares by exercise or conversion ($1.17M) · Sold 11,776 shares ($3.06M) |
| 12 Nov 2026 |
Form 4: Plewman Patrick, SVP for Diagnostic Services
Received 11,067 shares by exercise or conversion ($1.41M) · Sold 11,717 shares ($3.02M) |
| 05 Nov 2026 |
Form 4: Ramachandran Subu, SVP, Regional Businesses
Received 352 shares as a grant or award · Granted 1,386 Non-Qualifed Stock Option (right to buy) |
| 05 Nov 2026 |
Form 4: Doherty Catherine T., Executive Vice President
Received 4,827 shares as a grant or award · Received 22,105 shares by exercise or conversion ($2.69M) · Sold 22,105 shares ($5.48M) |
| 05 Nov 2026 |
Form 4: Delaney Mark E, SVP & Chief Commercial Officer
Received 2,615 shares as a grant or award |
| 28 Oct 2026 |
Form 4: Pfeiffer Gary M, Director
Sold 1,203 shares ($292K) |
| 23 Oct 2026 |
Form 4: Carter Robert B, Director
Acquired 10 shares (Small Acquisition) ($2.36K) |
| 23 Oct 2026 |
Form 4: Samad Sam, Executive Vice President & CFO
Received 90 shares as a grant or award ($21.2K) |
| 23 Oct 2026 |
Form 4: Gregg Vicky B, Director
Received 63 shares as a grant or award ($14.9K) |
| 23 Oct 2026 |
Form 4: Kuppusamy Karthik, SVP, Clinical Solutions
Acquired 33 shares (Small Acquisition) ($7.79K) |
| 23 Oct 2026 |
Form 4: Lassiter Wright Iii, Director
Acquired 6 shares (Small Acquisition) ($1.42K) |
| 23 Oct 2026 |
Form 4: Plewman Patrick, SVP for Diagnostic Services
Acquired 41 shares (Small Acquisition) ($9.67K) |
| 23 Oct 2026 |
Form 4: Main Timothy L, Director
Acquired 18 shares (Small Acquisition) ($4.25K) |
| 23 Oct 2026 |
Form 4: Delaney Mark E, SVP & Chief Commercial Officer
Acquired 25 shares (Small Acquisition) ($5.9K) |
| 02 Oct 2026 |
Form 4: Wentworth Timothy C, Director
Granted 135 Phantom Stock Units |
| 03 Sep 2026 |
Form 4: Davis J. E., Director
Sold 10,000 shares ($2.43M) |
| 31 Aug 2026 |
Form 4: Prevoznik Michael E, SVP & General Counsel
Received 22,677 shares by exercise or conversion ($2.54M) · Sold 22,677 shares ($5.51M) · Gave 1,000 shares as a gift |
| 29 Jul 2026 |
Form 4: Delaney Mark E, SVP & Chief Commercial Officer
Sold 1,600 shares ($376K) |
| 27 Jul 2026 |
Form 4: Kuppusamy Karthik, SVP, Clinical Solutions
Acquired 37 shares (Small Acquisition) ($7.65K) |
| 27 Jul 2026 |
Form 4: Carter Robert B, Director
Acquired 11 shares (Small Acquisition) ($2.27K) |
Loading...